Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ironwood Pharmaceuti
(NQ:
IRWD
)
4.980
+0.290 (+6.18%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Ironwood Pharmaceuti
< Previous
1
2
3
Next >
IRWD Stock Earnings: Ironwood Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024
August 08, 2024
IRWD stock results show that Ironwood Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Asana, Clover Health Investments, Hertz Global And Other Big Stocks Moving Higher On Friday
June 21, 2024
Via
Benzinga
IRWD Stock Earnings: Ironwood Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024
May 09, 2024
IRWD stock results show that Ironwood Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 09, 2024
Via
Benzinga
Stock Market Crash Warning: Don’t Get Caught Holding These 3 Biotech Stocks
April 30, 2024
As the stock market corrects, focusing on stable investments is crucial. This is why you should steer clear of these biotech stocks to avoid.
Via
InvestorPlace
Earnings Scheduled For February 15, 2024
February 15, 2024
Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million.
Via
Benzinga
A Preview Of Ironwood Pharmaceuticals's Earnings
February 14, 2024
Via
Benzinga
Chart Of The Day: Ironwood Pharma - Gastrointestinal Products
February 13, 2024
Via
Talk Markets
Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
May 09, 2024
Via
Benzinga
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In March
March 07, 2024
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Earnings Preview For Ironwood Pharmaceuticals
August 07, 2023
Via
Benzinga
It’s Time! 3 Failing Biotech Stocks to Sell Right Now
March 05, 2024
The biotech industry offers investors unique investment opportunities but these three are biotechs to sell.
Via
InvestorPlace
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 29, 2024
Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
February 29, 2024
Via
Benzinga
Stocks Mixed, Headed For Monthly Wins
February 29, 2024
In what appears to be a theme this week, stocks are hesitant midday as investors unpack this morning's jobs and inflation data.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
Why Is Gastrointestinal Healthcare Focused Ironwood Pharmaceuticals Stock Sinking On Thursday?
February 29, 2024
Ironwood Pharmaceuticals' SBS-IF treatment Apraglutide's Phase 3 trial met primary endpoints, reducing PS dependency by 25.5% vs. placebo, but misses on two key secondary endpoints.
Via
Benzinga
Nasdaq Gains 100 Points Following PCE Data
February 29, 2024
U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 100 points on Thursday. Following the market opening Thursday, the Dow traded down 0.07% to 38,923.11 while the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
PSNY Stock Alert: Polestar Makes Moves With Its Joint Venture
February 29, 2024
Polestar stock is rising higher on Thursday as holders of PSNY shares react to an update for the company's Chinese joint venture.
Via
InvestorPlace
Ironwood Pharmaceuticals Ran Up 32% Over Two Months — And Just Lost It All
February 29, 2024
The company still plans to ask for approval of its short bowel syndrome treatment.
Via
Investor's Business Daily
Tech Stocks Set To Rise Thursday As January Inflation Data Fails To Scare Markets, Small Caps Surge
February 29, 2024
Tech stocks drive pre-market surge, Fed inflation data fails to disrupt rate cut expectations. Futures up for Nasdaq, S&P 500, and small caps.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Why Is Ironwood Pharmaceuticals (IRWD) Stock Down 27% Today?
February 29, 2024
Ironwood Pharmaceuticals stock is falling on Thursday with investors in IRWD unimpressed by its latest Phase III clinical trial results.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 29, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
February 29, 2024
It's time to dive into the biggest pre-market stock movers for Thursday as we check out all of the news affecting shares this morning!
Via
InvestorPlace
Top 4 Health Care Stocks You May Want To Dump In February
February 15, 2024
As of Feb. 15, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Via
Benzinga
Why Terran Orbital Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 19, 2023
Gainers Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares jumped 124.2% to $0.1697 after falling 15% on Monday.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
September 28, 2023
Via
Benzinga
Orchestra BioMed, Vital Farms And Other Big Stocks Moving Higher On Tuesday
September 19, 2023
U.S. stocks traded lower on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Down 7% in 2023, This Struggling Growth Stock Could Soon Make a Turnaround
June 12, 2023
Ironwood's plan to purchase a smaller biotech should address some issues that have shareholders concerned.
Via
The Motley Fool
The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree
June 02, 2023
Big Pharma is facing a patent cliff that could siphon off billions in revenue.
Via
Investor's Business Daily
Why Ironwood Pharmaceuticals Stock Bumped Higher Today
May 22, 2023
Investors indicated approval of the company's upcoming $1 billion asset purchase.
Via
The Motley Fool
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.